A detailed history of Advisor Group Holdings, Inc. transactions in Dyadic International Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,000 shares of DYAI stock, worth $1,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$1,700
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.04 - $1.55 $1,040 - $1,550
1,000 New
1,000 $1,000
Q2 2021

Aug 02, 2021

SELL
$3.35 - $5.67 $3,350 - $5,670
-1,000 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$5.35 - $7.77 $4,280 - $6,216
800 Added 400.0%
1,000 $5,000
Q3 2020

Nov 12, 2020

SELL
$7.22 - $9.11 $341,101 - $430,392
-47,244 Reduced 99.58%
200 $2,000
Q2 2020

Aug 14, 2020

SELL
$4.93 - $10.26 $24,650 - $51,300
-5,000 Reduced 9.53%
47,444 $411,000
Q1 2020

May 18, 2020

BUY
$2.58 - $6.6 $135,305 - $346,130
52,444 New
52,444 $273,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $48.3M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.